
Overview
Dr. Christopher A. Rangel is a board-certified medical oncologist who specializes in managing patients with non-small cell lung cancer, small cell lung cancer, and thymic cancers. The Virginia Commonwealth University School of Medicine awarded his medical degree. He completed his internal medicine residency and his fellowship in hematology/oncology at the Medical University of South Carolina. Dr. Rangel is accepting new patients at Hollings Cancer Center in downtown Charleston and the MUSC Health East Cooper location in Mount Pleasant, SC.
His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Large-Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 1 peer reviewed article. Dr. Rangel is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
86 Jonathan Lucas St, Charleston, SC 29425
86 Jonathan Lucas St, Charleston, SC 29425
Additional Areas of Focus
Dr. Rangel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MUSC University Hospital
Scott Lindhorst is an Oncologist practicing medicine in Charleston, South Carolina. Dr. Lindhorst is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Brain Tumor, and Awake Craniotomy.
MUSC University Hospital
Robert Stuart is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Stuart is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
MUSC University Hospital
John Wrangle is an Oncologist practicing medicine in Charleston, South Carolina. Dr. Wrangle is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
Frequently Asked Questions about Dr. Christopher A. Rangel
How do I make an appointment with Dr. Christopher A. Rangel?
You can book an appointment with Dr. Christopher A. Rangel by calling their office at 843-792-9300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher A. Rangel a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher A. Rangel is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher A. Rangel specialize in?
While Dr. Christopher A. Rangel is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Large-Cell Lung Carcinoma, and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Christopher A. Rangel participate in research or clinical trials?
Yes. Dr. Christopher A. Rangel has published 1 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Christopher A. Rangel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher A. Rangel accept my insurance?
Dr. Christopher A. Rangel accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-792-9300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Rangel isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Rangel isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rangel isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rangel isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Rangel isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Rangel isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).